Prior to joining Health Enterprise Partners as General Partner in 2009, Dave Tamburri was a Vice President for Susquehanna Growth Equity, a private equity group focused on growth stage technology companies. He was formerly the President and Chief Operating Officer of Onward Healthcare, Inc., a Welsh, Carson, Anderson & Stowe portfolio company. Prior to Onward, Tamburri was an Executive Vice President of Pinnacor, Inc., a General Atlantic portfolio company, which went public.
Currently he is on the board of directors of Bardy Diagnostics, Catapult Health, eVariant, Intraprise Health, Jet Health, and Payer Compass. Tamburri previously served on the board of directors for HealthQx (acquired by McKesson), MobileMD (acquired by Siemens Healthcare), Nordic Consulting (recapitalized by Silversmith Capital Partners), Privia Health (merged with Brighton Health), Shyft Analytics (acquired by Medidata), and Vitals.
He is on the faculty of both Columbia Business School and the School of Professional Studies at Columbia University. In addition, Tamburri is a member of the Healthcare Initiative Advisory Board at Harvard Business School. He is a distinguished graduate of the United States Military Academy and holds an MBA from Harvard Business School.